ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1952

Lack of Association of a 6.7 Kbp Deletion of LILRA3 with Giant Cell Arteritis

Ana Márquez1, Tamara Fernández-Aranguren2, Maria C. Cid3, José Hernández-Rodríguez3, Roser Solans4, Marc Ramentol4, Santos Castañeda5, Jose A. Miranda-Filloy6, Inmaculada C. Morado7, Javier Narváez8, Eugenio De Miguel9, Bernardo Sopeña10, Jordi Monfort11, Maria Jesus Garcia-Villanueva12, Norberto Ortego-Centeno13, Torsten Witte14, Miguel Angel Gonzalez-Gay15, Javier Martín2 and Spanish GCA Group, 1Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS-Granada and Systemic Autoimmune Diseases Unit, Hospital Clínico San Cecilio, Granada, Spain, 2Instituto de Parasitología y Biomedicina López- Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain, 3Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, 4Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d’Hebron, Autonomous University of Barcelona, Barcelona, Spain, 5Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, 6Department of Rheumatology, Hospital Xeral-Calde, Lugo, Spain, 7Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 8Rheumatology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain, 9Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain, 10Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Spain, 11Department of Rheumatology, Grup de recerca cel•lular en inflamació i cartílag. IMIM (Institut de Recerca Hospital del Mar), Barcelona, Spain, 12Department of Rheumatology, Hospital Ramón y Cajal, Madrid, Spain, 13Systemic Autoimmune Diseases Unit, Hospital Clínico San Cecilio, Granada, Spain, 14Hannover Medical School, Hanover, Germany, 15Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Autoimmunity, giant cell arteritis and polymorphism

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Vasculitis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Leukocyte immunoglobulin-like receptor A3 (LILRA3A) encodes a member of a family of immunoreceptors which is predominantly expressed on antigen presenting cells, acting as a soluble receptor for class I major histocompatibility complex (MHC) antigens. Recently published studies have implicated a 6.7 kb genetic deletion of LILRA3, comprising the first seven exons of the gene, in the genetic predisposition to rheumatoid arthritis, multiple sclerosis, and Sjögren’s syndrome. Given the proposed role of LILRA3A in autoimmunity, we aimed to assess whether this deletion represents a novel genetic risk factor for GCA and its main clinical subgroups.

Methods: A total of 969 biopsy-proven GCA patients and 1593 healthy controls of Spanish Caucasian origin were included in the study. The LILRA3 deletion was genotyped by polymerase chain reaction using specific primers for detecting presence or absence of the complete gene.

Results: No statistically significant differences were found when allele and genotype distributions were compared between GCA patients and controls (allelic p-value= 0.924, OR=1.01, CI 95%=0.87-1.17). Likewise, the subphenotype analysis considering the main clinical complications of the disease (rheumatic polymyalgia, visual manifestations, jaw claudication and stroke) yield similar negative results.

Conclusion: Our data suggest that the LILRA3 deletion do not play a significant role in GCA susceptibility or severity.


Disclosure: A. Márquez, None; T. Fernández-Aranguren, None; M. C. Cid, None; J. Hernández-Rodríguez, None; R. Solans, None; M. Ramentol, None; S. Castañeda, None; J. A. Miranda-Filloy, None; I. C. Morado, None; J. Narváez, None; E. De Miguel, None; B. Sopeña, None; J. Monfort, None; M. J. Garcia-Villanueva, None; N. Ortego-Centeno, None; T. Witte, None; M. A. Gonzalez-Gay, None; J. Martín, None.

To cite this abstract in AMA style:

Márquez A, Fernández-Aranguren T, Cid MC, Hernández-Rodríguez J, Solans R, Ramentol M, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, De Miguel E, Sopeña B, Monfort J, Garcia-Villanueva MJ, Ortego-Centeno N, Witte T, Gonzalez-Gay MA, Martín J. Lack of Association of a 6.7 Kbp Deletion of LILRA3 with Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/lack-of-association-of-a-6-7-kbp-deletion-of-lilra3-with-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lack-of-association-of-a-6-7-kbp-deletion-of-lilra3-with-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology